AIIMS professor Balram Bhargava appointed DG of ICMR

New Delhi: AIIMS professor Balram Bhargava was appointed the Director General of Indian Council of Medical Research (ICMR) and Secretary of the Department of Health Research on Tuesday.

Bharagava, at present Professor/Senior Consultant Cardiologist at All India Institute of Medical Sciences (AIIMS) here, has been appointed to the post for a period of three years or until attainment of age of 60 years, according to an order issued by the Personnel Ministry.

The Delhi-based ICMR is one of the oldest medical research bodies in the world.

According to a separate order, renowned scientist Renu Swaroop has been appointed the Secretary of the Department of Biotechnology.

Swaroop, currently senior adviser in the same department, has been appointed to the post for a period of two years or until she attains 60 years of age, the ministry said.

  • Related Posts

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

    Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority